This allows classification into one of three Glucotypes: In patients with GT2 or GT3, we diagnose a Carbohydrate-Sensitive Phenotype (CSP) an innate (probably largely inherited) tendency to spike blood glucose after carbs, carefully labelled to explain the concept and consequences that resemble how patients and society deal with lactose or gluten sensitivity (a small portion of pasta please as I have CSP)
In cardiometabolic contexts such as DM2 and HTN, agents like SGLT2 inhibitors and AMPK/Sirtuin modulators illustrate how metabolic correction can dovetail with oxidative protection
PlexusDx Precision Peptide Genetic Test identifies key variants such as GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313each influencing how your body responds to GLP-1 therapy
41 Renal effects In people with type 2 diabetes at high risk of cardiovascular disease, liraglutide 1.8 mg daily over a median follow up of 3.8 years resulted in a 22% reduction in renal outcomes compared with placebo
The same color scheme was used to visualize the water probes